Segal Cancer Centre
Message from the Director
Oncology Interdisciplinary Teams
New Referrals
Cancer Treatment Unit
Oncology Nursing
Oncology Pharmacy
Radiation Oncology
Psychosocial Oncology Program
Hope & Cope
Cancer Nutrition Rehabilitation Center
Oncology and Aging Program
Palliative Care
Adolescent and Young Adult Oncology Program
Education and Training
Molecular Pathology
Peter Brojde Lung Cancer Centre
Rossy Cancer Network
Richard Margolese, MD

Herbert Black Chair in Surgical Oncology, McGill University
Professor, Departments of Surgery and Oncology, McGill University

Medical School
McGill University, Montreal, QC

Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, QC
Mount Sinai Hospital, New York, NY

Roswell Park Institute, Buffalo, NY                 

Clinical Specialties
Medical Oncology; Surgical Oncology; Breast Cancer.

Research Interests
Clinical trials of promising new anti-cancer therapies; Clinical trials in: breast cancer surgery, adjuvant therapy in breast cancer, breast cancer prevention.

Dr. Margolese has been involved in clinical research studies in breast cancer.  He and his colleagues have shown that radical breast surgery can be replaced by breast conserving surgery, that adding chemotherapy and hormone therapies such as tamoxifen can improve long-term outcomes by diminishing the recurrence rate.  In one of these trials comparing tamoxifen after surgery to surgery alone they showed that not only was the cure rate improved but that new cancers in the opposite breast were diminished.  This led to the idea of Prevention and, indeed, two prevention trials have successfully shown that approximately half of the cancers can be prevented in selective women with high risk profiles.  These trials continue and Dr. Margolese continues his involvement in modern clinical trials.

Additional information on Dr. Richard Margolese.